Skip to main content
Glama

Calendly

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations, the description discloses rich behavioral detail: it cascades through multiple lookup endpoints, degrades gracefully when GLEIF/OpenFIGI are unavailable, returns `figi_candidates` for ambiguous matches, and explicitly reports unresolved identifiers rather than omitting them. This is exactly the kind of context an agent needs beyond readOnly/idempotent hints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and the 'Use FIRST' directive, and it is well segmented by supported type. It is dense and somewhat long, with large parentheticals, but every section adds operational value; slightly tighter prose would make it perfect.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates thoroughly by describing return behavior: canonical identifiers with source labels, `figi_candidates` on ambiguity, `unresolved` entries, and graceful degradation. The supported input forms and failure semantics are covered well enough for an agent to call the tool correctly in most scenarios.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The description adds substantial meaning beyond the schema: `value` must be the entity name only, an issuer should be passed exactly as printed, and trailing security-class words will match nothing. It also clarifies that ISINs resolve to legal entities via GLEIF and that drug values accept brand or generic names, making parameter usage far more precise than the schema alone.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies the action ('resolve a user-spoken NAME to the canonical/official identifiers other tools require as input') and names specific output identifiers (CIK, ticker, LEI, FIGI, RxCUI). The example queries anchor real user intents, and the supported entity types ('company', 'drug') distinguish this from sibling profile/compare tools functionally.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

'Use FIRST whenever you have a name but need an ID' is an explicit and actionable usage rule, reinforced by input-form guidance for companies and drugs. However, it does not explicitly name sibling alternatives or state when not to use the tool, so it falls just short of a perfect score.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Calendly toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several research tools overlap heavily: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, discover_tools, and suggest_questions all route to the same underlying catalog. Similarly, bet_research, polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, and polymarket_kalshi_spread form a dense prediction-market cluster with fuzzy boundaries. The few Calendly tools are distinct, but they are drowned out by duplicative families.

Naming Consistency3/5

Most names use snake_case and a noun-based pattern (e.g. polymarket_edges, entity_profile), and several follow verb_noun (list_event_types, list_scheduled_events, resolve_entity). But there are standalone verbs (forget, recall, subscribe) and inconsistent verb styles (ask_ vs list_ vs scan_), so the pattern is readable but not predictable.

Tool Count2/5

36 tools is far too many for a server ostensibly named Calendly: only 5 tools relate to Calendly events and invitees, while 31 tools belong to an unrelated Pipeworx data-research platform. The count is bloated by a second domain bolted onto the server, making the surface hard to navigate for its apparent purpose.

Completeness2/5

For the Calendly domain implied by the server name, the surface is missing core operations: there is no create/update/cancel/delete event, no cancel or reschedule flow, no invitee management beyond listing, and no event-type creation or editing. The Pipeworx side is broader, but even it has gaps like no bulk data export or direct raw-tool invocation.

Resources